Gilead’s twice-yearly shot to prevent HIV succeeds in late-stage trial By: CNBC.com News June 20, 2024 at 11:22 AM EDT Gilead's experimental twice-yearly medicine to prevent HIV was 100% effective in a late-stage trial, the company said Thursday. Read More >>
